Wir sind mit live! Mehr erfahren
22,90 USD
-0,60
2,55 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
22,90
0,00
0 %
1 Tag
-2,55 %
5 Tage
-0,22 %
1 Monat
-8,29 %
3 Monate
-15,15 %
6 Monate
-15 %
Seit Jahresbeginn
5,58 %
1 Jahr
16,07 %
5 Jahre
-40,36 %
10 Jahre
-18,07 %
 

Profil: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Mitarbeiter: 12.000

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 73,2 %
Neutral 26,8 %
Negativ 0 %
Positiv
Zacks Investment Research
vor 7 Tagen
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Positiv
Zacks Investment Research
vor 8 Tagen
Here's Why Envista (NVST) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Envista (NVST) is a Strong Growth Stock
Neutral
PRNewsWire
vor 10 Tagen
Envista Schedules Third Quarter 2026 Earnings Call
BREA, Calif., Oct. 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2026 on Wednesday, November 4, 2026.
Envista Schedules Third Quarter 2026 Earnings Call
Positiv
Zacks Investment Research
vor 18 Tagen
New Strong Buy Stocks for September 28th
VG, HCSG, NVST, EQNR and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 28, 2026.
New Strong Buy Stocks for September 28th
Positiv
Zacks Investment Research
vor 21 Tagen
NVST vs. ABT: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
NVST vs. ABT: Which Stock Is the Better Value Option?
Positiv
Zacks Investment Research
vor 25 Tagen
Best Value Stocks to Buy for September 21st
SLDE, HHH and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 21st, 2026.
Best Value Stocks to Buy for September 21st
Positiv
Zacks Investment Research
vor 28 Tagen
Should Value Investors Buy Envista (NVST) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Envista (NVST) Stock?
Positiv
Zacks Investment Research
vor 28 Tagen
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Neutral
Seeking Alpha
vor 29 Tagen
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Positiv
Zacks Investment Research
vor 29 Tagen
Here's Why Envista (NVST) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Envista (NVST) is a Strong Value Stock
Kursdiagramme mit Lightweight Charts™ umgesetzt